{"id":"W2084549982","doi":"10.1111/apt.12863","title":"Escalation to weekly dosing recaptures response in adalimumab‐treated patients with moderately to severely active ulcerative colitis","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Generalitat Valenciana; AbbVie","keywords":"Dosing; Medicine; Adalimumab; Adverse effect; Ulcerative colitis; Internal medicine; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002359217,0.0001923969,0.0005753548,0.0001904313,0.0001581914,0.0003668313,0.0002005128,0.000264048,0.0008234686],"category_scores_gemma":[0.004821293,0.0001575895,0.0004424078,0.0002722421,0.0001287763,0.0003738888,0.0002422964,0.0005870227,0.0002272816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002201978,"about_ca_system_score_gemma":0.0001909145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002206234,"about_ca_topic_score_gemma":0.0002925087,"domain_scores_codex":[0.9986816,0.0007915382,0.0001262772,0.0001362408,0.000163873,0.0001004414],"domain_scores_gemma":[0.9974071,0.0009616122,0.001095898,0.0002218585,0.0000974185,0.0002161365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0663546,0.003942939,0.5730092,0.0003876661,0.0008205108,0.0003036704,0.0006245815,0.003491811,0.02929907,0.0001298066,0.001540363,0.3200959],"study_design_scores_gemma":[0.002408237,0.07266133,0.9124906,0.00006535321,0.0003283751,0.001007374,0.000107254,0.004932018,0.003655145,0.0001542022,0.002154884,0.00003523517],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998875,0.0005084093,0.0001881218,0.00004545172,0.000003480492,0.00002900788,0.00003303972,0.00001258923,0.0003050005],"genre_scores_gemma":[0.999486,0.00006733379,0.0002450458,0.00004627483,0.000006731178,0.00001551157,0.00005601433,0.000002096782,0.0000750063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002359217,"threshold_uncertainty_score":0.01247686,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01030489199654834,"score_gpt":0.2705890432070683,"score_spread":0.26028415121052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}